Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ERBB3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ERBB3 is a concept in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with Aging, Als, Cancer. Connected to 94 entities in the SciDEX knowledge graph.
| Name | ERBB3 |
| Key Genes/Proteins | ERBB2, CHONDROCYTE APOPTOSIS, CHONDROCYTE AUTOPHAGY, NDUFAF3 |
| Related Diseases | Ms, Cancer, Tumor, Als, Neuropathy |
| Related Pathways | oxidative stress response |
Knowledge base pages for this entity
graph TD
ERBB3["ERBB3"]
ERBB3 -->|"inhibits"| CHONDROCYTE_APOPTOSIS["CHONDROCYTE APOPTOSIS"]
ERBB3 -->|"activates"| CHONDROCYTE_AUTOPHAGY["CHONDROCYTE AUTOPHAGY"]
ERBB3 -->|"regulates"| Ms["Ms"]
ERBB3 -->|"activates"| Cancer["Cancer"]
ERBB3 -->|"activates"| Tumor["Tumor"]
ERBB3 -->|"interacts"| Als["Als"]
__HYDROXYBUTYRATE["Beta-HYDROXYBUTYRATE"] -->|"activates"| ERBB3
ErbB2["ErbB2"] -->|"interacts"| ERBB3
BACE1["BACE1"] -->|"target for"| ERBB3
ST6GAL1["ST6GAL1"] -->|"regulates"| ERBB3
APP["APP"] -->|"target for"| ERBB3
MAX["MAX"] -->|"regulates"| ERBB3
EGFR["EGFR"] -->|"target for"| ERBB3
FUT8["FUT8"] -->|"regulates"| ERBB3
ERK["ERK"] -->|"activates"| ERBB3
GAIN["GAIN"] -->|"activates"| ERBB3| Target | Relation | Type | Str |
|---|---|---|---|
| CHONDROCYTE APOPTOSIS | inhibits | gene | 0.80 |
| CHONDROCYTE AUTOPHAGY | activates | gene | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| Ms | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Neuropathy | associated_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Osteoarthritis | activates | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| Inflammation | treats | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tgf-Β | therapeutic_target | pathway | 0.60 |
| TP53 | activates | gene | 0.60 |
| MEIS1 | activates | gene | 0.60 |
| ELF3 | activates | gene | 0.60 |
| Akt | activates | pathway | 0.60 |
| Pi3K | activates | pathway | 0.60 |
| Mapk | activates | pathway | 0.60 |
| FUT8 | associated_with | gene | 0.60 |
| MAX | associated_with | gene | 0.60 |
| ST6GAL1 | associated_with | gene | 0.60 |
| Akt | therapeutic_target | pathway | 0.60 |
| Mapk | therapeutic_target | pathway | 0.60 |
| Pi3K | therapeutic_target | pathway | 0.60 |
| NRG1 | inhibits | gene | 0.60 |
| ERBB2 | associated_with | gene | 0.60 |
| SRC | interacts_with | gene | 0.60 |
| TCR | contributes_to | gene | 0.60 |
| FUT8 | regulates | gene | 0.60 |
| EGFR | contributes_to | gene | 0.60 |
| BACE1 | contributes_to | gene | 0.60 |
| ST6GAL1 | regulates | gene | 0.60 |
| APP | contributes_to | gene | 0.60 |
| MAX | regulates | gene | 0.60 |
| Tgf-Β | contributes_to | pathway | 0.60 |
| AKT | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| PHGDH | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Β-HYDROXYBUTYRATE | activates | gene | 0.90 |
| ERBB2 | interacts_with | protein | 0.90 |
| NDUFAF3 | associated_with | gene | 0.80 |
| BACE1 | therapeutic_target | gene | 0.60 |
| ST6GAL1 | regulates | gene | 0.60 |
| APP | therapeutic_target | gene | 0.60 |
| MAX | regulates | gene | 0.60 |
| EGFR | therapeutic_target | gene | 0.60 |
| FUT8 | regulates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| PHGDH | activates | gene | 0.60 |
| ACAT1 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| ERBB2 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| ACAT1 | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| ELF3 | therapeutic_target | gene | 0.60 |
| RET | inhibits | gene | 0.60 |
| ERBB2 | associated_with | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| TGFB1 | associated_with | gene | 0.60 |
| TGFBR2 | associated_with | gene | 0.60 |
| GATA3 | regulates | gene | 0.60 |
| CLDN4 | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| CDH1 | regulates | gene | 0.60 |
| ELF3 | activates | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| APP | contributes_to | gene | 0.60 |
| NRG1 | inhibits | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| ERBB4 | associated_with | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| TCR | therapeutic_target | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| RAS | activates | gene | 0.60 |
| MEIS1 | activates | gene | 0.60 |
| PDGFRA | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| BACE1 | associated_with | gene | 0.50 |
| Tgf-Β | associated_with | pathway | 0.50 |
| disease | associated_with | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||